ArticleSurgical case reports2025
Article in Surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHepatoblastoma with tumor thrombi involving three hepatic veins or extending into the inferior vena cava (IVC) toward the right atrium is mostly considered unresectable. In the current era of liver transplantation for unresectable hepatoblastoma with stable outcomes, it is challenging to choose extreme hepatectomy with hypothermic perfusion under total hepatic vascular exclusion. We herein report a successful case of extreme liver resection with CASE PRESENTATION: A 10-month-old girl was referred for an unresectable hepatoblastoma (alpha-fetoprotein [AFP] 592037 ng/mL), approximately 12 cm in size, occupying the right lobe with a tumoral thrombus extending into the IVC toward the right atrium. The tumor continued to involve three hepatic veins and the IVC after intensive chemotherapy, which was categorized into POSTTEXT III (P1, V3, M0) staging. We planned an
conclusionsResection of liver tumors invading the IVC or hepatic veins has become possible with technical lessons learned from liver transplantation skills. This procedure is a realistic option for achieving surgical cure and improving the quality of life in select pediatric patients with otherwise unresectable hepatoblastomas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.